Challenge
CDO and CMO of a rapidly growing biopharma company were dissatisfied with the growing cost overruns, quality challenges and delivery of existing full-service outsourcing (FSO) and Functional Service Provider (FSP) model.
Approach
Through a series of design sessions, fit-for-purpose benchmark gathering and SME interviews, developed a clear set of criteria, internal vs. FSO vs. FSP strategy and detailed cost modeling. Helped to down-select, negotiate with, and establish partnerships.
Impact
Strategy led to the selection of two alternate FSO CROs, two novel FSP categories, and a major internal build area. Supported a highly effective deployment, with governance and future operating model ways of working; to date, 20% cost reductions realized.
